Drug Database
Back to search

Poland· PL-100310312

Xigduo

A metformin and dapagliflozin product containing dapagliflozinum + metforminum, registered in Poland by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD15

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedXigduoATCA10BD15REGISTER NO.PL-100310312PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dapagliflozinum + metforminumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and dapagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD15 (metformin and dapagliflozin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search metformin and dapagliflozin products by name

Metformin and dapagliflozin · ATC A10BD15

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Dapagliflozinum + Metforminum
Manufacturer
AstraZeneca AB
Country
Poland (PL)
ATC code
A10BD15
ATC class
Metformin and dapagliflozin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05998426502664
  • gtin
    05902135480014
  • gtin
    05000456022958

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for metformin and dapagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and dapagliflozin against other medicinesHow interaction checks work

Metformin and dapagliflozin · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and dapagliflozin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Dapagliflozin/Metformin Hcs, Dapagliflozin/Metformin Reddy
  • Bulgaria · Dapagliflozin/Metformin Tchaikapharma, Дапаглифлозин/Метформин Полфарма
  • Cyprus · Mexdagry
  • Czechia · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Germany · Dapagliflozin/Metformin 089pharm, Dapagliflozin/Metformin 123 Acurae Pharma
  • Denmark · Dapagliflozin/Metformin Hydrochloride Juta, Dapagliflozin/Metformin Krka
  • Estonia · Mexdagry
  • Spain · Dapagliflozina/Metformina Aurovitas, Dapagliflozina/Metformina Krka
  • Finland · Dapagliflozin/Metformin Krka
  • France · Dapagliflozine/Chlorhydrate De Metformine Arrow, Dapagliflozine/Chlorhydrate De Metformine Krka
  • United Kingdom (Northern Ireland) · Dapagliflozin And Metformin Hydrochloride Milpharm, Dapagliflozin/Metformin Hydrochloride Torrent
  • Greece · Dapimefa, Mexdagry
  • Croatia · Dapagliflozin/Metforminklorid Krka, Dapagliflozin/Metforminklorid Krka D.D.
  • Hungary · Dapagliflozin/Metformin Pharmapath, Dapagliflozin/Metformin Polpharma
  • Ireland · Dapagliflozin/Metformin Krka
  • Iceland · Ebymect, Xigduo
  • Italy · Dapagliflozin E Metformina Aurobindo
  • Liechtenstein · Ebymect, Xigduo
  • Lithuania · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Latvia · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Malta · Dapagliflozin/Metformin Hydrochloride Aurobindo, Dapagliflozin/Metformin Hydrochloride Aurobindo Pharma
  • Netherlands · Dapaglozamet
  • Norway · Dapagliflozin/Metformin Krka, Ebymect
  • Portugal · Dapagliflozina + Metformina Farmoz, Dapagliflozina + Metformina Krka
  • Romania · Mexdagry
  • Sweden · Dapagliflozin/Metformin Elpen, Dapagliflozin/Metformin Krka
  • Slovenia · Mexdagry

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f840c85d-8b88-4a35-986c-fa0ef1b7a89f
GET /v1/drugs/f840c85d-8b88-4a35-986c-fa0ef1b7a89f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "5 mg + 1000 mg",
  "packaging": "05998426502664 ¦ Rp ¦ Skasowane ¦ EU/1/13/900/010 ¦ 16799\n60 tabl. w blistrze\n05902135480014 ¦ Rp ¦ EU/1/13/900/007 ¦ 104767\n14 tabl.\nRp ¦ EU/1/13/900/008 ¦ 104768\n28 tabl.\nRp ¦ EU/1/13/900/009 ¦ 104769\n56 tabl.\nRp ¦ EU/1/13/900/011 ¦ 104772\n60 tabl. w blistrze perforowanym\nRp ¦ EU/1/13/900/012 ¦ 104773\n196 tabl. (2 x 98)\n05000456022958 ¦ Rp ¦ EU/1/13/900/010 ¦ 129593\n60 tabl. w blistrze",
  "substance": "Dapagliflozinum 5 mg + Metformini hydrochloridum 1000 mg",
  "common_name": "Dapagliflozinum + Metforminum",
  "pl_product_id": "100310312",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about metformin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console